Nuveen’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Nuveen’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19.3K	Buy	+585	New	+$19.5K	﹤0.01%	4407

Other funds holding REVS

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

First Interstate Bank Billings, Montana $1.88B AUM 11.41% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Inscription Capital Houston, Texas $906M AUM 27.95% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

FFC

Frederick Financial Consultants Frederick, Maryland $241M AUM 15.61% 1-Year Est. Return

RIS

Richmond Investment Services Mequon, Wisconsin $316M AUM 19.72% 1-Year Est. Return

Pine Valley Investments Marlton, New Jersey $2.49B AUM 25.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Nuveen's REVS Position: Q3 2026 in Review

Nuveen opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q3 2026: 585 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #4407 among its holdings.

19 funds tracked by Wall St. Rank hold REVS as of Q3 2026.

Nuveen held 585 shares of Columbia Research Enhanced Value ETF worth $19.3K as of Q3 2026.
Columbia Research Enhanced Value ETF was a new Nuveen position in Q3 2026.
Columbia Research Enhanced Value ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4407 holding.
19 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.